Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama

References

1. Denève C., Janoir C., Poilane I., Fantinato C., Collignon A. 2009; New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents 33:Suppl 1S24–S28 [View Article][PubMed]
   [Google Scholar]
2. Dubberke E. R., Reske K. A., Yan Y., Olsen M. A., McDonald L. C., Fraser V. J. 2007; Clostridium difficile – associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45:1543–1549 [View Article][PubMed]
   [Google Scholar]
3. Freeman J., Bauer M. P., Baines S. D., Corver J., Fawley W. N., Goorhuis B., Kuijper E. J., Wilcox M. H. 2010; The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23:529–549 [View Article][PubMed]
   [Google Scholar]
4. Hecht D., Citron D. M., Cox M., Jacobus N., Jenkins S. G., Onderdonk A., Roe-Carpenter D., Rosenblatt J. E., Wexler H. M. 2007 Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard, 7th edn. Clinical and Laboratory Standards Institute document M11–A7 271–47 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
5. Hernández-Rocha C., Barra-Carrasco J., Pizarro-Guajardo M., Ibáñez P., Bueno S. M., Sarker M. R., Guzmán A. M., Alvarez-Lobos M., Paredes-Sabja D. 2012; Epidemic Clostridium difficile ribotype 027 in Chile. Emerg Infect Dis 18:1370–1372 [View Article][PubMed]
   [Google Scholar]
6. Labbé A.-C., Poirier L., MacCannell D., Louie T., Savoie M., Béliveau C., Laverdière M., Pépin J. 2008; Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 52:3180–3187 [View Article][PubMed]
   [Google Scholar]
7. Limbago B. M., Long C. M., Thompson A. D., Killgore G. E., Hannett G. E., Havill N. L., Mickelson S., Lathrop S., Jones T. F.& other authors ( 2009; Clostridium difficile strains from community-associated infections. J Clin Microbiol 47:3004–3007 [View Article][PubMed]
   [Google Scholar]
8. Loo V. G., Poirier L., Miller M. A., Oughton M., Libman M. D., Michaud S., Bourgault A. M., Nguyen T., Frenette C.& other authors ( 2005; A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353:2442–2449 [View Article][PubMed]
   [Google Scholar]
9. McDonald L. C., Killgore G. E., Thompson A., Owens R. C. Jr, Kazakova S. V., Sambol S. P., Johnson S., Gerding D. N. 2005; An epidemic, toxin gene-variant strain of Clostridium difficile.. N Engl J Med 353:2433–2441 [View Article][PubMed]
   [Google Scholar]
10. Miller M., Gravel D., Mulvey M., Taylor G., Boyd D., Simor A., Gardam M., McGeer A., Hutchinson J.& other authors ( 2010; Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 50:194–201 [View Article][PubMed]
    [Google Scholar]
11. Morgan O. W., Rodrigues B., Elston T., Verlander N. Q., Brown D. F. J., Brazier J., Reacher M. 2008; Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS ONE 3:e1812 [View Article][PubMed]
    [Google Scholar]
12. O’Connor J. R., Johnson S., Gerding D. N. 2009; Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136:1913–1924 [View Article][PubMed]
    [Google Scholar]
13. Pépin J., Valiquette L., Alary M. E., Villemure P., Pelletier A., Forget K., Pépin K., Chouinard D. 2004; Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171:466–472 [View Article][PubMed]
    [Google Scholar]
14. Quesada-Gómez C., Rodríguez C., Gamboa-Coronado M. M., Rodríguez-Cavallini E., Du T., Mulvey M. R., Villalobos-Zúñiga M., Boza-Cordero R. 2010; Emergence of Clostridium difficile NAP1 in Latin America. J Clin Microbiol 48:669–670 [View Article][PubMed]
    [Google Scholar]
15. Razavi B., Apisarnthanarak A., Mundy L. M. 2007; Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. Infection 35:300–307 [View Article][PubMed]
    [Google Scholar]
16. Spigaglia P., Mastrantonio P. 2004; Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 53:1129–1136 [View Article][PubMed]
    [Google Scholar]